Global Antimicrobial Peptides Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Global Antimicrobial Peptides Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Table of Contents
1 Study Coverage
1.1 Antimicrobial Peptides Product Introduction
1.2 Market by Type
1.2.1 Global Antimicrobial Peptides Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Plant Antimicrobial Peptides
1.2.3 Microbial Antimicrobial Peptides
1.2.4 Animal Antimicrobial Peptides
1.3 Market by Application
1.3.1 Global Antimicrobial Peptides Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Pharmaceuticals
1.3.3 Feed Additives
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Antimicrobial Peptides Market Size Estimates and Forecasts
2.1.1 Global Antimicrobial Peptides Revenue 2017-2028
2.1.2 Global Antimicrobial Peptides Sales 2017-2028
2.2 Antimicrobial Peptides Market Size by Region: 2022 Versus 2028
2.3 Antimicrobial Peptides Sales by Region (2017-2028)
2.3.1 Global Antimicrobial Peptides Sales by Region: 2017-2022
2.3.2 Global Antimicrobial Peptides Sales Forecast by Region (2023-2028)
2.3.3 Global Antimicrobial Peptides Sales Market Share by Region (2017-2028)
2.4 Antimicrobial Peptides Market Estimates and Projections by Region (2023-2028)
2.4.1 Global Antimicrobial Peptides Revenue by Region: 2017-2022
2.4.2 Global Antimicrobial Peptides Revenue Forecast by Region (2023-2028)
2.4.3 Global Antimicrobial Peptides Revenue Market Share by Region (2017-2028)
3 Global Antimicrobial Peptides by Manufacturers
3.1 Global Top Antimicrobial Peptides Manufacturers by Sales
3.1.1 Global Antimicrobial Peptides Sales by Manufacturer (2017-2022)
3.1.2 Global Antimicrobial Peptides Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top Antimicrobial Peptides Manufacturers by Revenue
3.2.1 Global Antimicrobial Peptides Revenue by Manufacturer (2017-2022)
3.2.2 Global Antimicrobial Peptides Revenue Share by Manufacturer (2017-2022)
3.3 Global Antimicrobial Peptides Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key Antimicrobial Peptides Manufacturers Covered: Ranking by Revenue
3.4.2 Global Antimicrobial Peptides Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global Antimicrobial Peptides Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Antimicrobial Peptides Manufacturing Base Distribution, Product Type
3.5.1 Antimicrobial Peptides Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Antimicrobial Peptides Product Type
3.5.3 Date of International Manufacturers Enter into Antimicrobial Peptides Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 AnaSpec
4.1.1 AnaSpec Corporation Information
4.1.2 AnaSpec Description, Business Overview
4.1.3 AnaSpec Antimicrobial Peptides Products Offered
4.1.4 AnaSpec Antimicrobial Peptides Sales, Revenue and Gross Margin (2017-2022)
4.1.5 AnaSpec Antimicrobial Peptides Sales by Product in 2021
4.1.6 AnaSpec Antimicrobial Peptides Sales by Application in 2021
4.1.7 AnaSpec Antimicrobial Peptides Sales by Geographic Area in 2021
4.1.8 AnaSpec Recent Developments
4.2 AMP Biotech
4.2.1 AMP Biotech Corporation Information
4.2.2 AMP Biotech Description, Business Overview
4.2.3 AMP Biotech Antimicrobial Peptides Products Offered
4.2.4 AMP Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2017-2022)
4.2.5 AMP Biotech Antimicrobial Peptides Sales by Product in 2021
4.2.6 AMP Biotech Antimicrobial Peptides Sales by Application in 2021
4.2.7 AMP Biotech Antimicrobial Peptides Sales by Geographic Area in 2021
4.2.8 AMP Biotech Recent Developments
4.3 Phoenix Biotech
4.3.1 Phoenix Biotech Corporation Information
4.3.2 Phoenix Biotech Description, Business Overview
4.3.3 Phoenix Biotech Antimicrobial Peptides Products Offered
4.3.4 Phoenix Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2017-2022)
4.3.5 Phoenix Biotech Antimicrobial Peptides Sales by Product in 2021
4.3.6 Phoenix Biotech Antimicrobial Peptides Sales by Application in 2021
4.3.7 Phoenix Biotech Antimicrobial Peptides Sales by Geographic Area in 2021
4.3.8 Phoenix Biotech Recent Developments
4.4 Novabiotics
4.4.1 Novabiotics Corporation Information
4.4.2 Novabiotics Description, Business Overview
4.4.3 Novabiotics Antimicrobial Peptides Products Offered
4.4.4 Novabiotics Antimicrobial Peptides Sales, Revenue and Gross Margin (2017-2022)
4.4.5 Novabiotics Antimicrobial Peptides Sales by Product in 2021
4.4.6 Novabiotics Antimicrobial Peptides Sales by Application in 2021
4.4.7 Novabiotics Antimicrobial Peptides Sales by Geographic Area in 2021
4.4.8 Novabiotics Recent Developments
4.5 Chinese Peptide
4.5.1 Chinese Peptide Corporation Information
4.5.2 Chinese Peptide Description, Business Overview
4.5.3 Chinese Peptide Antimicrobial Peptides Products Offered
4.5.4 Chinese Peptide Antimicrobial Peptides Sales, Revenue and Gross Margin (2017-2022)
4.5.5 Chinese Peptide Antimicrobial Peptides Sales by Product in 2021
4.5.6 Chinese Peptide Antimicrobial Peptides Sales by Application in 2021
4.5.7 Chinese Peptide Antimicrobial Peptides Sales by Geographic Area in 2021
4.5.8 Chinese Peptide Recent Developments
4.6 Ontores
4.6.1 Ontores Corporation Information
4.6.2 Ontores Description, Business Overview
4.6.3 Ontores Antimicrobial Peptides Products Offered
4.6.4 Ontores Antimicrobial Peptides Sales, Revenue and Gross Margin (2017-2022)
4.6.5 Ontores Antimicrobial Peptides Sales by Product in 2021
4.6.6 Ontores Antimicrobial Peptides Sales by Application in 2021
4.6.7 Ontores Antimicrobial Peptides Sales by Geographic Area in 2021
4.6.8 Ontores Recent Development
4.7 GenScript
4.7.1 GenScript Corporation Information
4.7.2 GenScript Description, Business Overview
4.7.3 GenScript Antimicrobial Peptides Products Offered
4.7.4 GenScript Antimicrobial Peptides Sales, Revenue and Gross Margin (2017-2022)
4.7.5 GenScript Antimicrobial Peptides Sales by Product in 2021
4.7.6 GenScript Antimicrobial Peptides Sales by Application in 2021
4.7.7 GenScript Antimicrobial Peptides Sales by Geographic Area in 2021
4.7.8 GenScript Recent Development
4.8 Hycult Biotech
4.8.1 Hycult Biotech Corporation Information
4.8.2 Hycult Biotech Description, Business Overview
4.8.3 Hycult Biotech Antimicrobial Peptides Products Offered
4.8.4 Hycult Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2017-2022)
4.8.5 Hycult Biotech Antimicrobial Peptides Sales by Product in 2021
4.8.6 Hycult Biotech Antimicrobial Peptides Sales by Application in 2021
4.8.7 Hycult Biotech Antimicrobial Peptides Sales by Geographic Area in 2021
4.8.8 Hycult Biotech Recent Development
4.9 Sunsmile
4.9.1 Sunsmile Corporation Information
4.9.2 Sunsmile Description, Business Overview
4.9.3 Sunsmile Antimicrobial Peptides Products Offered
4.9.4 Sunsmile Antimicrobial Peptides Sales, Revenue and Gross Margin (2017-2022)
4.9.5 Sunsmile Antimicrobial Peptides Sales by Product in 2021
4.9.6 Sunsmile Antimicrobial Peptides Sales by Application in 2021
4.9.7 Sunsmile Antimicrobial Peptides Sales by Geographic Area in 2021
4.9.8 Sunsmile Recent Development
4.10 Ruixing Biotechnology
4.10.1 Ruixing Biotechnology Corporation Information
4.10.2 Ruixing Biotechnology Description, Business Overview
4.10.3 Ruixing Biotechnology Antimicrobial Peptides Products Offered
4.10.4 Ruixing Biotechnology Antimicrobial Peptides Sales, Revenue and Gross Margin (2017-2022)
4.10.5 Ruixing Biotechnology Antimicrobial Peptides Sales by Product in 2021
4.10.6 Ruixing Biotechnology Antimicrobial Peptides Sales by Application in 2021
4.10.7 Ruixing Biotechnology Antimicrobial Peptides Sales by Geographic Area in 2021
4.10.8 Ruixing Biotechnology Recent Development
4.11 Zhongnong Yingtai Biotechnology
4.11.1 Zhongnong Yingtai Biotechnology Corporation Information
4.11.2 Zhongnong Yingtai Biotechnology Description, Business Overview
4.11.3 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Products Offered
4.11.4 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales, Revenue and Gross Margin (2017-2022)
4.11.5 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales by Product in 2021
4.11.6 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales by Application in 2021
4.11.7 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales by Geographic Area in 2021
4.11.8 Zhongnong Yingtai Biotechnology Recent Development
4.12 Glam Technology
4.12.1 Glam Technology Corporation Information
4.12.2 Glam Technology Description, Business Overview
4.12.3 Glam Technology Antimicrobial Peptides Products Offered
4.12.4 Glam Technology Antimicrobial Peptides Sales, Revenue and Gross Margin (2017-2022)
4.12.5 Glam Technology Antimicrobial Peptides Sales by Product in 2021
4.12.6 Glam Technology Antimicrobial Peptides Sales by Application in 2021
4.12.7 Glam Technology Antimicrobial Peptides Sales by Geographic Area in 2021
4.12.8 Glam Technology Recent Development
4.13 ProteLight Pharmaceutical & Biotechnology
4.13.1 ProteLight Pharmaceutical & Biotechnology Corporation Information
4.13.2 ProteLight Pharmaceutical & Biotechnology Description, Business Overview
4.13.3 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Products Offered
4.13.4 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales, Revenue and Gross Margin (2017-2022)
4.13.5 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales by Product in 2021
4.13.6 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales by Application in 2021
4.13.7 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales by Geographic Area in 2021
4.13.8 ProteLight Pharmaceutical & Biotechnology Recent Development
5 Breakdown Data by Type
5.1 Global Antimicrobial Peptides Sales by Type (2017-2028)
5.1.1 Global Antimicrobial Peptides Sales by Type (2017-2022)
5.1.2 Global Antimicrobial Peptides Sales Forecast by Type (2023-2028)
5.1.3 Global Antimicrobial Peptides Sales Market Share by Type (2017-2028)
5.2 Global Antimicrobial Peptides Revenue Forecast by Type (2017-2028)
5.2.1 Global Antimicrobial Peptides Revenue by Type (2017-2022)
5.2.2 Global Antimicrobial Peptides Revenue Forecast by Type (2023-2028)
5.2.3 Global Antimicrobial Peptides Revenue Market Share by Type (2017-2028)
5.3 Antimicrobial Peptides Average Selling Price (ASP) by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Antimicrobial Peptides Sales by Application (2017-2028)
6.1.1 Global Antimicrobial Peptides Sales by Application (2017-2022)
6.1.2 Global Antimicrobial Peptides Sales Forecast by Application (2023-2028)
6.1.3 Global Antimicrobial Peptides Sales Market Share by Application (2017-2028)
6.2 Global Antimicrobial Peptides Revenue Forecast by Application (2017-2028)
6.2.1 Global Antimicrobial Peptides Revenue by Application (2017-2022)
6.2.2 Global Antimicrobial Peptides Revenue Forecast by Application (2023-2028)
6.2.3 Global Antimicrobial Peptides Revenue Market Share by Application (2017-2028)
6.3 Antimicrobial Peptides Average Selling Price (ASP) by Application (2017-2028)
7 North America
7.1 North America Antimicrobial Peptides Market Size YoY Growth 2017-2028
7.2 North America Antimicrobial Peptides Market Facts & Figures by Country
7.2.1 North America Antimicrobial Peptides Sales by Country (2017-2028)
7.2.2 North America Antimicrobial Peptides Revenue by Country (2017-2028)
7.3 North America Antimicrobial Peptides Sales by Type
7.4 North America Antimicrobial Peptides Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Antimicrobial Peptides Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Antimicrobial Peptides Market Facts & Figures by Region
8.2.1 Asia-Pacific Antimicrobial Peptides Sales by Region (2017-2028)
8.2.2 Asia-Pacific Antimicrobial Peptides Revenue by Region (2017-2028)
8.3 Asia-Pacific Antimicrobial Peptides Sales by Type
8.4 Asia-Pacific Antimicrobial Peptides Sales by Application
9 Europe
9.1 Europe Antimicrobial Peptides Market Size YoY Growth 2017-2028
9.2 Europe Antimicrobial Peptides Market Facts & Figures by Country
9.2.1 Europe Antimicrobial Peptides Sales by Country (2017-2028)
9.2.2 Europe Antimicrobial Peptides Revenue by Country (2017-2028)
9.3 Europe Antimicrobial Peptides Sales by Type
9.4 Europe Antimicrobial Peptides Sales by Application
10 Latin America
10.1 Latin America Antimicrobial Peptides Market Size YoY Growth 2017-2028
10.2 Latin America Antimicrobial Peptides Market Facts & Figures by Country
10.2.1 Latin America Antimicrobial Peptides Sales by Country (2017-2028)
10.2.2 Latin America Antimicrobial Peptides Revenue by Country (2017-2028)
10.3 Latin America Antimicrobial Peptides Sales by Type
10.4 Latin America Antimicrobial Peptides Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Antimicrobial Peptides Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Antimicrobial Peptides Market Facts & Figures by Country
11.2.1 Middle East and Africa Antimicrobial Peptides Sales by Country (2017-2028)
11.2.2 Middle East and Africa Antimicrobial Peptides Revenue by Country (2017-2028)
11.3 Middle East and Africa Antimicrobial Peptides Sales by Type
11.4 Middle East and Africa Antimicrobial Peptides Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Antimicrobial Peptides Supply Chain Analysis
12.2 Antimicrobial Peptides Key Raw Materials and Upstream Suppliers
12.3 Antimicrobial Peptides Clients Analysis
12.4 Antimicrobial Peptides Sales Channel and Sales Model Analysis
12.4.1 Antimicrobial Peptides Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Antimicrobial Peptides Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Antimicrobial Peptides Distributors
13 Market Dynamics
13.1 Antimicrobial Peptides Industry Trends
13.2 Antimicrobial Peptides Market Drivers
13.3 Antimicrobial Peptides Market Challenges
13.4 Antimicrobial Peptides Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Antimicrobial Peptides Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Manufacturers of Plant Antimicrobial Peptides
Table 3. Major Manufacturers of Microbial Antimicrobial Peptides
Table 4. Major Manufacturers of Animal Antimicrobial Peptides
Table 5. Global Antimicrobial Peptides Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Antimicrobial Peptides Market Size by Region (US$ Million): 2021 VS 2022 VS 2028
Table 7. Global Antimicrobial Peptides Sales by Region (2017-2022) & (Mg)
Table 8. Global Antimicrobial Peptides Sales Forecast by Region (2023-2028) & (Mg)
Table 9. Global Antimicrobial Peptides Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Antimicrobial Peptides Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 11. Global Antimicrobial Peptides Sales by Manufacturer (2017-2022) & (Mg)
Table 12. Global Antimicrobial Peptides Sales Share by Manufacturer (2017-2022)
Table 13. Antimicrobial Peptides Revenue by Manufacturer (2017-2022) & (US$ Million)
Table 14. Antimicrobial Peptides Revenue Share by Manufacturer (2017-2022)
Table 15. Key Manufacturers Antimicrobial Peptides Price (2017-2022) & (US$/Mg)
Table 16. Ranking of Global Top Antimicrobial Peptides Manufacturers by Revenue (US$ Million) in 2021
Table 17. Global Antimicrobial Peptides Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 18. Global Antimicrobial Peptides by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antimicrobial Peptides as of 2021)
Table 19. Antimicrobial Peptides Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Antimicrobial Peptides Product Type
Table 21. Date of International Manufacturers Enter into Antimicrobial Peptides Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. AnaSpec Corporation Information
Table 24. AnaSpec Description and Business Overview
Table 25. AnaSpec Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
Table 26. AnaSpec Antimicrobial Peptides Product
Table 27. AnaSpec Antimicrobial Peptides Sales Proportion of Antimicrobial Peptides by Product in 2021
Table 28. AnaSpec Antimicrobial Peptides Sales Proportion of Antimicrobial Peptides by Application in 2021
Table 29. AnaSpec Antimicrobial Peptides Sales Proportion of Antimicrobial Peptides by Geographic Area in 2021
Table 30. AnaSpec Recent Development
Table 31. AMP Biotech Corporation Information
Table 32. AMP Biotech Description and Business Overview
Table 33. AMP Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
Table 34. AMP Biotech Antimicrobial Peptides Product
Table 35. AMP Biotech Antimicrobial Peptides Sales Proportion of Antimicrobial Peptides by Product in 2021
Table 36. AMP Biotech Antimicrobial Peptides Sales Proportion of Antimicrobial Peptides by Application in 2021
Table 37. AMP Biotech Antimicrobial Peptides Sales Proportion of Antimicrobial Peptides by Geographic Area in 2021
Table 38. AMP Biotech Recent Development
Table 39. Phoenix Biotech Corporation Information
Table 40. Phoenix Biotech Description and Business Overview
Table 41. Phoenix Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
Table 42. Phoenix Biotech Antimicrobial Peptides Product
Table 43. Phoenix Biotech Antimicrobial Peptides Sales Proportion of Antimicrobial Peptides by Product in 2021
Table 44. Phoenix Biotech Antimicrobial Peptides Sales Proportion of Antimicrobial Peptides by Application in 2021
Table 45. Phoenix Biotech Antimicrobial Peptides Sales Proportion of Antimicrobial Peptides by Geographic Area in 2021
Table 46. Phoenix Biotech Recent Development
Table 47. Novabiotics Corporation Information
Table 48. Novabiotics Description and Business Overview
Table 49. Novabiotics Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
Table 50. Novabiotics Antimicrobial Peptides Product
Table 51. Novabiotics Antimicrobial Peptides Sales Proportion of Antimicrobial Peptides by Product in 2021
Table 52. Novabiotics Antimicrobial Peptides Sales Proportion of Antimicrobial Peptides by Application in 2021
Table 53. Novabiotics Antimicrobial Peptides Sales Proportion of Antimicrobial Peptides by Geographic Area in 2021
Table 54. Novabiotics Recent Development
Table 55. Chinese Peptide Corporation Information
Table 56. Chinese Peptide Description and Business Overview
Table 57. Chinese Peptide Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
Table 58. Chinese Peptide Antimicrobial Peptides Product
Table 59. Chinese Peptide Antimicrobial Peptides Sales Proportion of Antimicrobial Peptides by Product in 2021
Table 60. Chinese Peptide Antimicrobial Peptides Sales Proportion of Antimicrobial Peptides by Application in 2021
Table 61. Chinese Peptide Antimicrobial Peptides Sales Proportion of Antimicrobial Peptides by Geographic Area in 2021
Table 62. Chinese Peptide Recent Development
Table 63. Ontores Corporation Information
Table 64. Ontores Description and Business Overview
Table 65. Ontores Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
Table 66. Ontores Antimicrobial Peptides Product
Table 67. Ontores Antimicrobial Peptides Sales Proportion of Antimicrobial Peptides by Product in 2021
Table 68. Ontores Antimicrobial Peptides Sales Proportion of Antimicrobial Peptides by Application in 2021
Table 69. Ontores Antimicrobial Peptides Sales Proportion of Antimicrobial Peptides by Geographic Area in 2021
Table 70. GenScript Corporation Information
Table 71. GenScript Description and Business Overview
Table 72. GenScript Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
Table 73. GenScript Antimicrobial Peptides Product
Table 74. GenScript Antimicrobial Peptides Sales Proportion of Antimicrobial Peptides by Product in 2021
Table 75. GenScript Antimicrobial Peptides Sales Proportion of Antimicrobial Peptides by Application in 2021
Table 76. GenScript Antimicrobial Peptides Sales Proportion of Antimicrobial Peptides by Geographic Area in 2021
Table 77. Hycult Biotech Corporation Information
Table 78. Hycult Biotech Description and Business Overview
Table 79. Hycult Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
Table 80. Hycult Biotech Antimicrobial Peptides Product
Table 81. Hycult Biotech Antimicrobial Peptides Sales Proportion of Antimicrobial Peptides by Product in 2021
Table 82. Hycult Biotech Antimicrobial Peptides Sales Proportion of Antimicrobial Peptides by Application in 2021
Table 83. Hycult Biotech Antimicrobial Peptides Sales Proportion of Antimicrobial Peptides by Geographic Area in 2021
Table 84. Sunsmile Corporation Information
Table 85. Sunsmile Description and Business Overview
Table 86. Sunsmile Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
Table 87. Sunsmile Antimicrobial Peptides Product
Table 88. Sunsmile Antimicrobial Peptides Sales Proportion of Antimicrobial Peptides by Product in 2021
Table 89. Sunsmile Antimicrobial Peptides Sales Proportion of Antimicrobial Peptides by Application in 2021
Table 90. Sunsmile Antimicrobial Peptides Sales Proportion of Antimicrobial Peptides by Geographic Area in 2021
Table 91. Ruixing Biotechnology Corporation Information
Table 92. Ruixing Biotechnology Description and Business Overview
Table 93. Ruixing Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
Table 94. Ruixing Biotechnology Antimicrobial Peptides Product
Table 95. Ruixing Biotechnology Antimicrobial Peptides Sales Proportion of Antimicrobial Peptides by Product in 2021
Table 96. Ruixing Biotechnology Antimicrobial Peptides Sales Proportion of Antimicrobial Peptides by Application in 2021
Table 97. Ruixing Biotechnology Antimicrobial Peptides Sales Proportion of Antimicrobial Peptides by Geographic Area in 2021
Table 98. Zhongnong Yingtai Biotechnology Corporation Information
Table 99. Zhongnong Yingtai Biotechnology Description and Business Overview
Table 100. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
Table 101. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product
Table 102. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales Proportion of Antimicrobial Peptides by Product in 2021
Table 103. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales Proportion of Antimicrobial Peptides by Application in 2021
Table 104. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales Proportion of Antimicrobial Peptides by Geographic Area in 2021
Table 105. Glam Technology Corporation Information
Table 106. Glam Technology Description and Business Overview
Table 107. Glam Technology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
Table 108. Glam Technology Antimicrobial Peptides Product
Table 109. Glam Technology Antimicrobial Peptides Sales Proportion of Antimicrobial Peptides by Product in 2021
Table 110. Glam Technology Antimicrobial Peptides Sales Proportion of Antimicrobial Peptides by Application in 2021
Table 111. Glam Technology Antimicrobial Peptides Sales Proportion of Antimicrobial Peptides by Geographic Area in 2021
Table 112. ProteLight Pharmaceutical & Biotechnology Corporation Information
Table 113. ProteLight Pharmaceutical & Biotechnology Description and Business Overview
Table 114. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
Table 115. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Product
Table 116. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales Proportion of Antimicrobial Peptides by Product in 2021
Table 117. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales Proportion of Antimicrobial Peptides by Application in 2021
Table 118. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales Proportion of Antimicrobial Peptides by Geographic Area in 2021
Table 119. Global Antimicrobial Peptides Sales by Type (2017-2022) & (Mg)
Table 120. Global Antimicrobial Peptides Sales Forecast by Type (2023-2028) & (Mg)
Table 121. Global Antimicrobial Peptides Revenue by Type (2017-2022) & (US$ Million)
Table 122. Global Antimicrobial Peptides Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 123. Global Antimicrobial Peptides Sales by Application (2017-2022) & (Mg)
Table 124. Global Antimicrobial Peptides Sales Forecast by Application (2023-2028) & (Mg)
Table 125. Global Antimicrobial Peptides Revenue by Application (2017-2022) & (US$ Million)
Table 126. Global Antimicrobial Peptides Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 127. North America Antimicrobial Peptides Sales by Country (2017-2022) & (Mg)
Table 128. North America Antimicrobial Peptides Sales by Country (2023-2028) & (Mg)
Table 129. North America Antimicrobial Peptides Revenue by Country (2017-2022) & (US$ Million)
Table 130. North America Antimicrobial Peptides Revenue by Country (2023-2028) & (US$ Million)
Table 131. North America Antimicrobial Peptides Sales by Type (2017-2022) & (Mg)
Table 132. North America Antimicrobial Peptides Sales by Application (2017-2022) & (Mg)
Table 133. Asia-Pacific Antimicrobial Peptides Sales by Region (2017-2022) & (Mg)
Table 134. Asia-Pacific Antimicrobial Peptides Sales by Region (2023-2028) & (Mg)
Table 135. Asia-Pacific Antimicrobial Peptides Revenue by Region (2017-2028) & (US$ Million)
Table 136. Asia-Pacific Antimicrobial Peptides Revenue by Region (2023-2028) & (US$ Million)
Table 137. Asia-Pacific Antimicrobial Peptides Sales by Type (2017-2022) & (Mg)
Table 138. Asia-Pacific Antimicrobial Peptides Sales by Application (2017-2022) & (Mg)
Table 139. Europe Antimicrobial Peptides Sales by Country (2017-2022) & (Mg)
Table 140. Europe Antimicrobial Peptides Sales by Country (2023-2028) & (Mg)
Table 141. Europe Antimicrobial Peptides Revenue by Country (2017-2022) & (US$ Million)
Table 142. Europe Antimicrobial Peptides Revenue by Country (2023-2028) & (US$ Million)
Table 143. Europe Antimicrobial Peptides Sales by Type (2017-2022) & (Mg)
Table 144. Europe Antimicrobial Peptides Sales by Application (2017-2022) & (Mg)
Table 145. Latin America Antimicrobial Peptides Sales by Country (2017-2022) & (Mg)
Table 146. Latin America Antimicrobial Peptides Sales by Country (2023-2028) & (Mg)
Table 147. Latin America Antimicrobial Peptides Revenue by Country (2017-2022) & (US$ Million)
Table 148. Latin America Antimicrobial Peptides Revenue by Country (2023-2028) & (US$ Million)
Table 149. Latin America Antimicrobial Peptides Sales by Type (2017-2022) & (Mg)
Table 150. Latin America Antimicrobial Peptides Sales by Application (2017-2022) & (Mg)
Table 151. Middle East and Africa Antimicrobial Peptides Sales by Country (2017-2022) & (Mg)
Table 152. Middle East and Africa Antimicrobial Peptides Sales by Country (2023-2028) & (Mg)
Table 153. Middle East and Africa Antimicrobial Peptides Revenue by Country (2017-2022) & (US$ Million)
Table 154. Middle East and Africa Antimicrobial Peptides Revenue by Country (2023-2028) & (US$ Million)
Table 155. Middle East and Africa Antimicrobial Peptides Sales by Type (2017-2022) & (Mg)
Table 156. Middle East and Africa Antimicrobial Peptides Sales by Application (2017-2022) & (Mg)
Table 157. Antimicrobial Peptides Key Raw Materials, Industry Status and Trend
Table 158. Antimicrobial Peptides Key Raw Materials and Upstream Suppliers
Table 159. Antimicrobial Peptides Clients Status and Trend
Table 160. Antimicrobial Peptides Typical Clients
Table 161. Antimicrobial Peptides Distributors
Table 162. Antimicrobial Peptides Market Trends
Table 163. Antimicrobial Peptides Market Drivers
Table 164. Antimicrobial Peptides Market Challenges
Table 165. Antimicrobial Peptides Market Restraints
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Antimicrobial Peptides Product Picture
Figure 2. Global Antimicrobial Peptides Sales Market Share by Type in 2021 & 2028
Figure 3. Plant Antimicrobial Peptides Product Picture
Figure 4. Microbial Antimicrobial Peptides Product Picture
Figure 5. Animal Antimicrobial Peptides Product Picture
Figure 6. Global Antimicrobial Peptides Sales Market Share by Application in 2021 & 2028
Figure 7. Pharmaceuticals Examples
Figure 8. Feed Additives Examples
Figure 9. Others Examples
Figure 10. Antimicrobial Peptides Report Years Considered
Figure 11. Global Antimicrobial Peptides Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Antimicrobial Peptides Market Size 2017-2028 (US$ Million)
Figure 13. Global Antimicrobial Peptides Sales 2017-2028 (Mg)
Figure 14. Global Antimicrobial Peptides Market Size Market Share by Region: 2022 Versus 2028
Figure 15. Global Antimicrobial Peptides Sales Market Share Forecast by Region (2017-2028)
Figure 16. Global Antimicrobial Peptides Revenue Market Share by Region (2017-2028)
Figure 17. Global Antimicrobial Peptides Sales Share by Manufacturer in 2021
Figure 18. Antimicrobial Peptides Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 19. Global Antimicrobial Peptides Sales Market Share Forecast by Type (2017-2028)
Figure 20. Global Antimicrobial Peptides Revenue Market Share Forecast by Type (2017-2028)
Figure 21. Antimicrobial Peptides

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs